No matter how high the inflation is, their demand is inelastic. No matter how slow the current profit growth is, these companies spend on research and development (R&D) for future growth.
Taysha Gene Therapies, Inc.’s TSHA share price has dipped by 11.15%, which has investors questioning if this is right time to buy.
US stocks fell as President Trump's deadline to impose reciprocal tariffs on US trading partners creeps closer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback